RxSight, Inc.
RXST
$8.43
$0.212.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -11.24% | -5.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.24% | -5.77% | |||
| Cost of Revenue | -11.70% | -16.28% | |||
| Gross Profit | -11.08% | -1.59% | |||
| SG&A Expenses | 1.19% | 1.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.91% | -0.56% | |||
| Operating Income | -31.19% | -23.71% | |||
| Income Before Tax | -43.83% | -37.90% | |||
| Income Tax Expenses | 77.78% | 50.00% | |||
| Earnings from Continuing Operations | -43.91% | -37.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -43.91% | -37.93% | |||
| EBIT | -31.19% | -23.71% | |||
| EBITDA | -33.54% | -22.00% | |||
| EPS Basic | -43.08% | -37.46% | |||
| Normalized Basic EPS | -42.98% | -37.36% | |||
| EPS Diluted | -43.08% | -37.46% | |||
| Normalized Diluted EPS | -42.98% | -37.36% | |||
| Average Basic Shares Outstanding | 0.58% | 0.38% | |||
| Average Diluted Shares Outstanding | 0.58% | 0.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||